Alnylam Pharmaceuticals
ALNY
#565
Rank
โ‚ฌ36.66 B
Marketcap
277,56ย โ‚ฌ
Share price
-0.93%
Change (1 day)
3.75%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company